Extended-release buprenorphine in pregnancy

Alexander Hubbell, Ese Aghenta, Cresta Jones, Sheila Specker

Research output: Contribution to journalArticlepeer-review

Abstract

Background and Objectives: The relative safety and efficacy of monthly extended-release buprenorphine (XR-BUP) has not been fully evaluated in pregnant persons. Methods: Case report of two pregnant individuals receiving XR-BUP while pregnant. Results: Both patients had positive experiences and healthy infants. Discussion and Conclusions: Sparse data regarding the use of XR-BUP in pregnant patients limits shared decision-making. Additional evidence will support the growing population of pregnant patients exposed to XR-BUP. Scientific Significance: Positive patient experiences using XR-BUP during pregnancy have been previously unreported. This report will contribute to discussions of risks and benefits for future patients using XR-BUP during pregnancy.

Original languageEnglish (US)
Pages (from-to)354-356
Number of pages3
JournalAmerican Journal on Addictions
Volume33
Issue number3
DOIs
StatePublished - May 2024

Bibliographical note

Publisher Copyright:
© 2024 The Authors. The American Journal on Addictions published by Wiley Periodicals LLC on behalf of The American Academy of Addiction Psychiatry (AAAP).

PubMed: MeSH publication types

  • Case Reports

Fingerprint

Dive into the research topics of 'Extended-release buprenorphine in pregnancy'. Together they form a unique fingerprint.

Cite this